Ophthalmic Plast Reconstr Surg
March 2012
Purpose: We sought to evaluate the efficacy of topical 3% diclofenac gel in the management of periocular actinic keratosis.
Methods: Four consecutive patients with periocular actinic keratosis who were treated with topical 3% diclofenac gel twice daily for up to 4 months were included in the study. Patients were reviewed at 1 and 2 months and then as clinically required up to 13 months after treatment.